We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This is going to pop when all the punters who are scared of nasdaq listing are out.Lots of news due next few weeks
I don't hold this share currently. However, I noticed they are planning to cancel the Aim shares and convert them to ADS. It is worth checking that your broker platform is OK with this. If held in an Isa or a Sipp there are likely to be issues with some service providers. See the Verona Pharma thread as there were issues when they cancelled their Aim shares in favour of ADS
From 8:00am right the way to gone 2pm today - every recorded trade was a Buy (including myself taking advantage of the dip) - and from 2pm to close it was roughly a 50:50 split.
Directors buying with confidence and market activity leaning firmly towards accumulation can only mean that we are early adopters and will be in for a ride.....
Don't loose sight of the fact that MPH only launched on LSE four years ago at mid £2.30's - a tad over 700% rise from todays closing price. Or a 90% drop from ATH circa £3.50 - upside potential is huge - and nobody does upside potential quite like the Pharma sector.
Madness current price equates to 36.8p converted to nasdaq
Big director buy again someones confidant news on the horizon.
Good show of confidence by the Directors buying at this level from the positive RNS release this evening. Hopefully this will help in stopping the slow drift downwards and will give investors a good base to start buying again.
This is the most unexciting share in my portfolio. Except slowly drifting downwards off the back of some small trades it seems to do nothing. Not sure what it will take to wake up and get some momentum.
https://www.lse.co.uk/rns/MPH/changes-to-board-of-directors-dspt0iyp5wlxznb.html
Very odd. Nothing more to say.
Fake drop looking at bid/sell price at the time of recent trades. Spring coiling IMO. GLA.
On the ask
Some have been spiked
More good news soon i think
Fake shake, buys showing in red. Strong hold.
Agree!
Nasdaq will love this news.
Gla well pleased
Bought in cheap a couple of weeks ago with a note 31/10/2020. End of P3 trial for one of their candidates??
Lots of buying friday
3.04 dollars after hours
Should fly monday
This share is very leaky lol
This broker forecast is same for about 10 months now . I am still in proffit but share price is dropping and there is no volume at the moment . Torn what to do with it it has big potential. Covid news massive spike and sudden drop what worries me the most you would think it was great news. Any thoughts?
This broker forecast is same for about 10 months now . I am still in proffit but share price is dropping and there is no volume at the moment . Torn what to do with it it has big potential. Covid news massive spike and sudden drop what worries me the most you would think it was great news. Any thoughts?
thanks. I did see the 650p target, but i thought that must be old or based on something else. particularly when the TP on the $ line is $8, so c180% upside.
Also from FT Share analysis:
https://markets.ft.com/data/equities/tearsheet/forecasts?s=MPH:LSE
"The one analyst offering a 12 month price target expects Mereo BioPharma Group PLC share price to rise to 650.00 in the next year from the last price of 48.00."
An increase of 1,254.2%..!
Just need to go through financials released to find basics, but 1 forecast in the U.S prices the future sp at $8 which would equate to around £6 over here, which is a Market Cap of just over 2 Billion at current dilution. Currently funded. I have to say this seems a hidden gem atm. Should the trials do well, I see an sp acceleration quickly!
"The 1 analysts offering 12-month price forecasts for Mereo BioPharma Group plc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +172.11% increase from the last price of 2.94."
Evening, I’m relatively new to this stock and have been monitoring for the past 4-6 weeks. I can’t find any broker forecast / reports on it for the London listing. Should I be looking only for reports on the US listing? Any insight would be appreciated. Thank you.
Yes I liked the RNS. Aftercare for a continuing problem with Covid-19. The biggest issue is the attack on the respiratory system of the individual and anything that can help with that particular problem is a sure fire way to treat and mend the patient back to good health.
Mph finally will take part of Covid19